GXEA.F
Lakefront Biotherapeutics NV
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
24.60
▲ 0.40 (1.65%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
24.60
Prev close
24.20
Day high
24.60
Day low
24.60
Volume
86
Market cap
$1.61B
P/E (TTM)
2.73
52W range
22.40 – 31.40
Day trading desk
Gap from prior close
+1.65%
Prior close 24.20
VWAP
—
—
Relative volume
—
—
Session range
—
24.60 – 24.60
Position in range
—
—
ATR (14D)
0.50
2.03% of price
Prior day high
24.20
PDH
Prior day low
24.20
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.36%
+4.5%
1M
0.00%
-3.4%
3M
+4.24%
+1.8%
6M
-13.99%
-25.9%
YTD
-11.51%
-23.5%
1Y
-9.56%
-29.8%
3Y
-25.90%
-101.0%
5Y
-47.66%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on GXEA.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
334.15M
Total on file
Fundamentals
Market cap$1.61B
Enterprise value$29.54B
Revenue (TTM)$990.57M
Gross profit$669.75M
EBITDA$568.92M
Net income$594.32M
EPS (TTM)$9.02
Free cash flow$138.21M
Total cash$2.24B
Total debt$6.36M
Book value / share$2.49
Shares outstanding65.48M
Float483.00M
Short % of float—
Dividend yield—
Beta (5Y)0.11
Valuation & profitability ratios
Trailing P/E2.73
Forward P/E-6.32
PEG ratio—
Price / sales—
Price / book9.90
EV / revenue29.83
EV / EBITDA51.93
Gross margin67.61%
Operating margin-359.30%
Profit margin60.23%
Return on equity20.12%
Return on assets9.93%
Debt / equity0.20
Current ratio32.84
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.11B | $275.65M | $239.72M | $241.25M | +303.5% |
| Operating revenue | $1.11B | $275.65M | $239.72M | $241.25M | +303.5% |
| Cost of revenue | $29.74M | $34.86M | $0 | $0 | -14.7% |
| Gross profit | $1.08B | $240.79M | $239.72M | $241.25M | +349.6% |
| Research & development | $459.42M | $335.46M | $241.29M | $269.80M | +37.0% |
| Selling, general & admin | $111.96M | $96.88M | $94.25M | $103.31M | +15.6% |
| Total operating expense | $581.12M | $429.12M | $327.99M | $372.31M | +35.4% |
| Operating income | $501.39M | -$188.34M | -$88.26M | -$131.06M | +366.2% |
| Net interest income | $45.19M | $89.46M | $77.64M | $8.71M | -49.5% |
| Pre-tax income | $300.87M | -$3.08M | $5.63M | -$70.85M | +9,852.7% |
| Tax provision | -$18.62M | -$1.80M | $9.61M | $572.00K | -932.8% |
| Net income | $320.88M | $74.08M | $211.70M | -$217.99M | +333.1% |
| Net income to common | $320.88M | $74.08M | $211.70M | -$217.99M | +333.1% |
| Basic EPS | 4.87 | 1.12 | 3.21 | -3.32 | +334.8% |
| Diluted EPS | 4.87 | 1.12 | 3.21 | -3.32 | +334.8% |
| EBIT | $303.09M | -$2.17M | $7.39M | -$61.69M | +14,041.5% |
| EBITDA | $358.96M | $43.33M | $51.04M | $3.87M | +728.5% |
| Basic shares | 65.90M | 66.14M | 65.88M | 65.66M | -0.4% |
| Diluted shares | 65.90M | 66.14M | 65.88M | 65.66M | -0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $87.87M | $64.24M | $166.80M | $508.12M | +36.8% |
| Cash & short-term investments | $3.00B | $3.12B | $3.68B | $4.09B | -3.8% |
| Accounts receivable | $9.57M | $32.47M | $17.49M | $28.19M | -70.5% |
| Inventory | $22.49M | $51.19M | $73.98M | $52.92M | -56.1% |
| Total current assets | $3.08B | $3.34B | $3.86B | $4.24B | -7.8% |
| Property, plant & equipment | $80.66M | $122.90M | $126.32M | $154.25M | -34.4% |
| Goodwill & intangibles | $848.00K | $234.87M | $197.46M | $216.17M | -99.6% |
| Total assets | $3.41B | $4.14B | $4.36B | $4.73B | -17.6% |
| Total current liabilities | $152.86M | $335.08M | $428.22M | $522.54M | -54.4% |
| Total debt | $6.92M | $11.72M | $9.60M | $21.90M | -41.0% |
| Total liabilities | $170.65M | $1.24B | $1.56B | $2.21B | -86.2% |
| Retained earnings | $210.58M | -$134.31M | -$228.27M | -$496.69M | +256.8% |
| Shareholder equity | $3.24B | $2.90B | $2.80B | $2.53B | +11.7% |
| Working capital | $2.93B | $3.00B | $3.43B | $3.71B | -2.6% |
| Net tangible assets | $3.24B | $2.66B | $2.60B | $2.31B | +21.5% |
| Shares issued | 65.90M | 65.90M | 65.90M | 65.84M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $320.88M | $74.08M | $211.70M | -$217.99M | +333.1% |
| Depreciation & amortisation | $55.88M | $45.50M | $43.64M | $65.57M | +22.8% |
| Stock-based compensation | $24.00M | $19.89M | $56.72M | $88.51M | +20.7% |
| Change in working capital | -$876.57M | -$320.55M | -$692.43M | -$379.47M | -173.5% |
| Operating cash flow | -$257.46M | -$320.03M | -$405.97M | -$500.54M | +19.6% |
| Capital expenditure | -$13.86M | -$82.11M | -$19.27M | -$36.95M | +83.1% |
| Investing cash flow | $288.81M | $220.60M | $71.19M | -$1.25B | +30.9% |
| Financing cash flow | -$3.27M | -$4.92M | -$5.00M | -$1.49M | +33.5% |
| Free cash flow | -$271.31M | -$402.14M | -$425.24M | -$537.49M | +32.5% |
| End cash position | $87.87M | $64.24M | $166.81M | $508.12M | +36.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $6.48M | $900.82M | $71.16M | $65.29M | $74.98M | -99.3% |
| Operating revenue | $6.48M | $900.82M | $71.16M | $65.29M | $74.98M | -99.3% |
| Cost of revenue | $4.80M | $455.00K | $10.85M | $4.71M | $13.73M | +954.7% |
| Gross profit | $1.68M | $900.37M | $60.31M | $60.58M | $61.25M | -99.8% |
| Research & development | $30.96M | $107.51M | $73.88M | $95.28M | $182.75M | -71.2% |
| Selling, general & admin | $35.51M | $2.94M | $46.42M | $18.80M | $43.80M | +1,106.4% |
| Total operating expense | $65.39M | $141.57M | $101.99M | $117.61M | $219.96M | -53.8% |
| Operating income | -$63.70M | $758.80M | -$41.67M | -$57.03M | -$158.71M | -108.4% |
| Net interest income | $13.42M | $14.75M | $9.27M | $9.39M | $11.78M | -9.0% |
| Pre-tax income | $13.96M | $783.15M | -$221.49M | -$104.42M | -$156.37M | -98.2% |
| Tax provision | $70.00K | $666.00K | -$17.50M | $26.00K | -$1.81M | -89.5% |
| Net income | $14.49M | $782.15M | -$202.11M | -$105.75M | -$153.40M | -98.1% |
| Net income to common | $14.49M | $782.15M | -$202.11M | -$105.75M | -$153.40M | -98.1% |
| Basic EPS | 0.22 | — | — | — | -2.33 | — |
| Diluted EPS | 0.22 | — | — | — | -2.33 | — |
| EBIT | -$63.70M | $560.50M | $2.42M | -$101.12M | -$158.71M | -111.4% |
| EBITDA | -$63.70M | $560.50M | $2.42M | -$101.12M | -$158.71M | -111.4% |
| Basic shares | 65.87M | — | — | — | 65.84M | — |
| Diluted shares | 65.87M | — | — | — | 65.84M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $66.81M | $87.87M | $64.46M | $71.67M | $108.07M | -24.0% |
| Cash & short-term investments | $2.98B | $3.00B | $3.05B | $3.09B | $3.30B | -0.5% |
| Accounts receivable | $21.74M | $9.57M | $45.33M | $55.50M | $51.15M | +127.2% |
| Inventory | $17.69M | $22.49M | $22.95M | $33.79M | $38.52M | -21.3% |
| Total current assets | $3.06B | $3.08B | $3.16B | $3.26B | $3.47B | -0.6% |
| Property, plant & equipment | $76.95M | $80.66M | $105.62M | $109.69M | $113.22M | -4.6% |
| Goodwill & intangibles | $746.00K | $848.00K | $7.42M | $216.58M | $225.96M | -12.0% |
| Total assets | $3.37B | $3.41B | $3.51B | $3.82B | $4.02B | -1.0% |
| Total current liabilities | $100.42M | $152.86M | $366.56M | $402.95M | $437.04M | -34.3% |
| Total debt | $6.43M | $6.92M | $7.50M | $8.44M | $10.86M | -6.9% |
| Total liabilities | $119.06M | $170.65M | $1.06B | $1.17B | $1.27B | -30.2% |
| Retained earnings | $228.33M | $210.58M | -$577.74M | -$380.80M | -$280.81M | +8.4% |
| Shareholder equity | $3.25B | $3.24B | $2.45B | $2.64B | $2.75B | +0.5% |
| Working capital | $2.96B | $2.93B | $2.80B | $2.85B | $3.04B | +1.2% |
| Net tangible assets | $3.25B | $3.24B | $2.44B | $2.43B | $2.52B | +0.5% |
| Shares issued | 65.90M | 65.90M | 65.90M | 65.90M | 65.90M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $14.49M | $782.15M | -$202.11M | -$105.75M | -$153.40M | -98.1% |
| Change in working capital | -$35.44M | -$813.79M | -$57.83M | -$57.21M | $52.26M | +95.6% |
| Operating cash flow | -$82.75M | -$47.46M | -$62.61M | -$108.78M | -$38.61M | -74.4% |
| Capital expenditure | -$123.00K | -$1.60M | -$2.85M | -$4.16M | -$5.25M | +92.3% |
| Investing cash flow | $61.50M | $72.62M | $56.74M | $74.71M | $84.75M | -15.3% |
| Financing cash flow | -$510.00K | -$405.00K | -$1.26M | -$600.00K | -$1.01M | -25.9% |
| Free cash flow | -$82.87M | -$49.06M | -$65.46M | -$112.94M | -$43.86M | -68.9% |
| End cash position | $66.81M | $87.87M | $64.46M | $71.67M | $108.07M | -24.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $28.98M | -59.3% |
| Next quarter | — | — | $72.72M | -91.9% |
| Current year | — | — | $94.87M | -91.5% |
| Next year | — | — | $93.29M | -1.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders25.45%
Held by institutions23.64%
Institutions holding99
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
24.20
+1.65% from price
SMA 20
23.86
+3.10% from price
SMA 50
24.89
-1.16% from price
SMA 100
24.51
+0.36% from price
SMA 200
26.11
-5.78% from price
EMA 12
24.18
+1.73% from price
EMA 26
24.29
+1.26% from price
EMA 50
24.54
+0.26% from price
RSI (14)
52.6
Neutral
MACD (12,26,9)
-0.11
Hist 0.17
ATR (14)
0.50
2.03% of price
Realised vol 30D
34.6%
Annualised
Bollinger upper
25.31
20, 2σ
Bollinger lower
22.41
20, 2σ
50 / 200 cross
Death
24.89 vs 26.11
Trend bias
Below 200
-5.78%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.17
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
34.6%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-28.7%
Peak to trough
Max drawdown 5Y
-68.7%
Peak to trough
ATR 14
0.50
2.03% of price
Beta (reported)
0.11
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 11, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 11, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Feb 25, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Nov 7, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Oct 22, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Oct 21, 25 | Leerink Partners | UPGRADE | Market Perform | Outperform |
| Feb 14, 25 | Morgan Stanley | DOWNGRADE | Equal-Weight | Underweight |
| Jan 23, 25 | Barclays | DOWNGRADE | Equal-Weight | Underweight |
| Nov 1, 24 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Sep 9, 24 | Leerink Partners | INITIATED | — | Market Perform |
| Apr 22, 24 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Apr 1, 24 | B of A Securities | DOWNGRADE | Neutral | Underperform |
Headlines
EverQuote (EVER) Shares Skyrocket, What You Need To Know
StockStory · 5m ago
Exxon Drops as Oil Retreats From $94
GuruFocus.com · 6m ago
Johnson & Johnson Rises 1.3% as Investors Seek Stability
GuruFocus.com · 7m ago
A $500,000 Annuity Pays About $3,100 a Month. Waiting Until 70 to Claim Social Security Pays More, and Its Raise Comes Every January.
24/7 Wall St. · 8m ago
Eli Lilly Slips as Its $1.1 Trillion Valuation Cools
GuruFocus.com · 8m ago
Nvidia's valuation looks surprisingly cheap heading into earnings. Could it be an issue for the stock?
Yahoo Finance · 9m ago
U.S. Stocks Mixed With Nasdaq Slipping on Weakness in Tech Sector
The Wall Street Journal · 9m ago
Current Standardizes Its $600M Firm Network on a Single Platform
PR Newswire · 9m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.